Arbutus Biopharma Corp (ABUS) — Capital Reinvestment Ratio
Arbutus Biopharma Corp (ABUS) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($20.62 Million) in capital expenditures ($75.00K). Check Arbutus Biopharma Corp tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arbutus Biopharma Corp Capital Reinvestment Ratio (2012–2012)
This chart tracks Arbutus Biopharma Corp's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ABUS cash generation efficiency.
Annual Capital Reinvestment Ratio for Arbutus Biopharma Corp (2012–2012)
Year-by-year Capital Reinvestment Ratio for Arbutus Biopharma Corp from 2012 to 2012. See ABUS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 0.00x | $33.27 Million | $14.90K | — |